Spyre Therapeutics Inc
(NAS:SYRE)
$
90.39
-3.25 (-3.47%)
Market Cap: 7.97 Bil
Enterprise Value: 6.97 Bil
PE Ratio: 0
PB Ratio: 8.34
GF Score: 26/100 Spyre Therapeutics Inc (SYRE) Transcripts
- 1